glp-1 glp Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Its a powerful way to support your health and weight What is GLP-1? The Hormone

The advantages of GLP-1 agonists include substantial clinical trial data supporting their efficacy and safety, FDA approval for weight management in certain populations, proven results with many users losing 15-20% or more of body weight, and effects on appetite that make caloric restriction feel natural

Compared to the number of psychiatric AEs reported in 2021 ( n = 935) and 2022 ( n = 893), the psychiatric AEs of GLP-1 RAs reported in Q1 alone in 2023 reached a whopping 411 cases, demonstrating the growing clinical use of GLP-1 RAs

PROFILES OF MAJOR PRODUCERS The Largest Producers on The Market and Their Profiles 11

3ko), which is a fibrotic ECM factor